Similarly, STAT3 signaling is frequently upregulated in both TNBC and HR+ BC, where it promotes tumor progression by driving the accumulation of immunosuppressive cell types such as Tregs and MDSCs, which further inhibit effective immune responses. The gene discussed is STAT3; the disease is breast cancer.